Furthermore, Fan and colleagues have described a functional role for ICOS in the anti-tumor immune response (31), providing a rationale for the combination of DC immunotherapy and engagement of ICOS-signaling in future treatments. The gene discussed is ICOS; the disease is neoplasm.